Cambrex to Acquire PharmaCore for $25 Million
By
Cambrex has agreed to acquire PharmaCore, a High Point, North Carolina-based company specializing in developing and manufacturing small-molecule active pharmaceutical ingredients (APIs), for approximately $25 million. PharmaCore develops and produces…
Particle Sciences, Glenmark Partner
By
Glenmark Pharmaceuticals, headquartered in Mumbai, India, has entered into a strategic development, license, and commercialization agreement with Particle Sciences, a Bethlehem, Pennsylvania-based contract development and manufacturing organization and part of…
Pfizer Completes $14 Billion Acquisition of Medivation
By
Pfizer has completed its previously announced $14 billion acquisition of Medivation, a San Francisco-based biopharmaceutical company, following completion of the antitrust review under the Hart-Scott-Rodino Antitrust Improvements Act of 1976,…
Eleven Biotherapeutics Acquires Viventia Bio
By
Eleven Biotherapeutics, a Cambridge, Massachusetts-based clinical-stage pharmaceutical company developing anti-cancer agents, has acquired Viventia Bio, Winnipeg, Canada-based biopharmaceutical company. Under the agreement, Eleven purchased all of the outstanding capital stock…
Antitrust Period Ends for Pfizer’$14 Billion Acquisition of Medivation
By
Pfizer has moved closer to closing its $14-billion acquisition of Medivation, a San Francisco-based biopharmaceutical company with the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.…